A Study Testing HIV-1 Drug Resistance By Ultra-Deep Sequencing After Short Course Of Zidovudine Single-Dose Of Nevirapine And Single-Dose Of Tenofovir Disoproxil Fumarate With Emtricitabine For Prevention Of Mother-To-Child Transmission (pMTCT).

Trial Profile

A Study Testing HIV-1 Drug Resistance By Ultra-Deep Sequencing After Short Course Of Zidovudine Single-Dose Of Nevirapine And Single-Dose Of Tenofovir Disoproxil Fumarate With Emtricitabine For Prevention Of Mother-To-Child Transmission (pMTCT).

Completed
Phase of Trial: Phase IV

Latest Information Update: 05 Jan 2017

At a glance

  • Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary) ; Nevirapine (Primary) ; Zidovudine (Primary)
  • Indications HIV-1 infections
  • Focus Pharmacodynamics; Therapeutic Use
  • Most Recent Events

    • 05 Jan 2017 New trial record
    • 01 Dec 2016 Results (n=26) published in the JAIDS:Journal of acquired immune deficiency syndromes.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top